The integrated treatment of peritoneal carcinomatosis. A preliminary experience

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 2, 1999, Pages 151-158

  Cavaliere, F ^a   Di Filippo, F ^a   Cosimelli, M ^a   Aloe, L ^a   Arcuri, E ^a   Anza M ^a   Callopoli, A ^a   Di Laura, L ^a   Morace, E ^a   Botti, C ^a   Natoli, S ^a   Tedesco, M ^a   Giunta, S ^b   Cavaliere, R ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

Hyperthermic antiblastic perfusion; Intra abdominal chemotherapy; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; APPENDIX CARCINOMA; ARTICLE; CANCER SURGERY; CARCINOMATOSIS; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG INDICATION; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MALIGNANT MESOTHELIOMA; OVARY CARCINOMA; PATIENT SELECTION; PRIORITY JOURNAL; STOMACH CARCINOMA; TREATMENT OUTCOME;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; AGED; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCINS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 0032797478     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sugarbaker P.H.: Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Ed. Sugarbaker P.H. Kluwer Academic Publishers, Boston, Peritoneal Carcinomatosis: Principles and Management. 1996; 79-100.
2. Yamada S., Takeda T., Matsumoto K.: Prognostic analysis of malignant pleural and peritoneal effusions. Cancer 51:136-140, 1983.
3. Sugarbaker P.H.: Peritonectomy procedures. Ann. Surg. 221: 29-42, 1995.
4. Sugarbaker P.H., Jablowski K.A.: Prognostic features of 51 colorectal and 130 appendiceal patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surgery 221:124-132, 1995.
5. Vidal-Jove S., Steves M.A., Banex-Sese G., Litwin F.P., Sugarbaker P.H.: Curative approach to pseudomixoma peritonei. Contemp. Surg. 38:13-21, 1991.
6. Mottolese M., Salzano M., Vincenzoni C., Benevolo M., Bigotti A., Iacovelli A., Lombardi A., Atlante G., Natali P.G.: The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors. Cancer 68:1803-1807, 1991.
7. Mottolese M., Carlini S., Cavaliere R.: Diagnosi immunocitochimica di lavaggi peritoneali in pazienti portatori di carcinoma gastrico: incremento dell'accuratezza diagnostica. Proceedings of the XI National Meeting of Experimental and Clinical Oncology 1993; Bari, 17-20 October.
8. Di Filippo F., Calabrò A.M., Giannarelli D., Carlini S., Cavaliere F., Moscarelli F. and Cavaliere R.: Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer 63:2552-2561, 1989.
9. Weiss L. Metastatic inefficiency. Adv Cancer Res 54: 159-211, 1990.
10. Sugarbaker T., Chang D., Koslowe P., Sugarbaker P.H.: Pathobiology of peritoneal carcinomatosis from ovarian malignancy. In: Peritoneal Carcinomatosis; Principles of Management, Sugarbaker P.H. eds. Kluwer Academic Publishes, Boston 1996; 63-74.
11. Sugarbaker P.H., Chang D., Koslowe P.: Peritoneal carcinomatosis from appendiceal cancer: a paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy. Acta Chir. Austriaca 1: 4-8, 1996.
12. Sugarbaker P.H.: Pseudomixoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann. Surg. 219:109-111, 1994.
13. Meyers M.A. Distribution of intra-abdominal malignant seeding: Dependency on dynamics of flow of ascitic fluid. Am. J. Roentgenol Radium. Ther. Nucl. Med. 119:198-206, 1973.
14. Shimatsuma M., Sakuyama A., Sirasu M., Hagiwara A., Takahashi T.: The role of the lymphatic system of the greater omentum and diaphragm in intraperitoneal cancer dissemination. Jpn J Lymphol 26:90-101, 1993.
15. Sugarbaker P.H.: Rule of least margins: rational for surgical treatment planning in gastrointestinal cancer. Reg Cancer Treatment 4: 116-120, 1991.
16. Sugarbaker P.H.: Peritoneal carcinomatosis from large bowel and appendiceal cancer: A new approach to treatment. Postgrad. Adv. Colorectal. Surg. 11:1-14, 1991.
17. Sugarbaker P.H., Kern K., Lack E.: Malignant pseudomixoma of colonic origin. Natural history and presentation of a curative approach to treatment. Dis. Colon Rectum 31:1-4, 1988.
18. Sugarbaker P.H., Schellinx Met, Chang D., Koslowe P., Von Meyerfeldt M.: Peritoneal carcinomatosis from adenocarcinoma of the colon. World J. Surg. 20:585-592, 1996.
19. Sugarbaker P.H., Fernàndez-Trigo V.: Evolution of local-regional treatment strategies in a curative approach to patients with malignant peritoneal mesothelioma. Surgical Rounds 9:369-374, 1996.
20. Stephens A.D., Belliveau J.F., Sugarbaker P.H.: Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. In: Sugarbaker P.H. eds. Peritoneal Carcinomatosis: Drugs and Diseases, Kluwer Academic Publishes, Boston 1996; 15-30.
21. Cavaliere F., Cosimelli M., Civalleri D., Forestieri P., Tedesco M., Consolo S., Giunta S., Perri P., Cavaliere R.: Postoperative intraperitoneal chemotherapy as adjuvant treatment of resectable gastric cancer. Reg. Cancer Treat. 4:199-203, 1993.
22. Sugarbaker P.H., Graves T., DeBruijn E.A., Cunliffe W.J., Mullins R.E., Hull W.E., Oliff L., Schlag P.: Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: Pharmacological studies. Cancer Res. 50: 5790-5794, 1990.
23. Park J.G., Kramer B.S., Steinberg S.M. et al.: Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium based calorimetric assay. Cancer Res. 47: 5875-5879, 1987.
24. Averbach A.M., Sugarbaker P.H.: Methodologie considerations in treatment using intraperitoneal chemotherapy. In: Peritoneal Carcinomatosis; Principles of Management, Sugarbaker P.H. eds. Kluwer Academic Publishes, Boston 1996; 289-310.
25. Greco C., Cavaliere R., Di Filippo F., Leonetti C., Zupi G.: A human melanoma line established in vivo: a valid model for cancer therapy studies. Proceedings of the 14th International Cancer Congress 1986; 2:681.
26. Fujimoto S., Shresta R.D., Kokubun M. et al.: Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far.advanced gastric cancer. Ann. Surg. 1990; 212: 592-596.
27. Natali P.G., Mottolese M., Venturo I., Salzano M., Perrone Donnorso R., Bigotti A., Atlante G.: Improvement of cytodiagnosis of ovarian tumors employing monoclonal antibodies. Mancuso S. eds. Achievements in Gynecology 1989-90. Contrib Gynecol Obstetric. Basel, arger, 1991 18:93-102.